Taysha Gene Therapies shares owned by Vanguard Asset Management
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Vanguard Asset Management
from 13F filings
Historical chart of Vanguard Asset Management investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Vanguard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $404k | 91k | 4.47 |